questionsmedicales.fr
Actions chimiques et utilisations
Actions pharmacologiques
Effets physiologiques des médicaments
Agents neuromédiateurs
Agents adrénergiques
Agents adrénergiques : Questions médicales fréquentes
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Agents adrénergiques : Questions médicales les plus fréquentes",
"headline": "Agents adrénergiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Agents adrénergiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-03",
"dateModified": "2026-02-23",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Agents adrénergiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Agents neuromédiateurs",
"url": "https://questionsmedicales.fr/mesh/D018377",
"about": {
"@type": "MedicalCondition",
"name": "Agents neuromédiateurs",
"code": {
"@type": "MedicalCode",
"code": "D018377",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Agonistes adrénergiques",
"alternateName": "Adrenergic Agonists",
"url": "https://questionsmedicales.fr/mesh/D000322",
"about": {
"@type": "MedicalCondition",
"name": "Agonistes adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D000322",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.100"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Agonistes alpha-adrénergiques",
"alternateName": "Adrenergic alpha-Agonists",
"url": "https://questionsmedicales.fr/mesh/D000316",
"about": {
"@type": "MedicalCondition",
"name": "Agonistes alpha-adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D000316",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.100.100"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Agonistes des récepteurs alpha-1 adrénergiques",
"alternateName": "Adrenergic alpha-1 Receptor Agonists",
"url": "https://questionsmedicales.fr/mesh/D058646",
"about": {
"@type": "MedicalCondition",
"name": "Agonistes des récepteurs alpha-1 adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D058646",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.100.100.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Agonistes des récepteurs alpha-2 adrénergiques",
"alternateName": "Adrenergic alpha-2 Receptor Agonists",
"url": "https://questionsmedicales.fr/mesh/D058647",
"about": {
"@type": "MedicalCondition",
"name": "Agonistes des récepteurs alpha-2 adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D058647",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.100.100.200"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Agonistes des récepteurs alpha-1 adrénergiques",
"alternateName": "Adrenergic alpha-1 Receptor Agonists",
"url": "https://questionsmedicales.fr/mesh/D058646",
"about": {
"@type": "MedicalCondition",
"name": "Agonistes des récepteurs alpha-1 adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D058646",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.100.100.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Agonistes des récepteurs alpha-2 adrénergiques",
"alternateName": "Adrenergic alpha-2 Receptor Agonists",
"url": "https://questionsmedicales.fr/mesh/D058647",
"about": {
"@type": "MedicalCondition",
"name": "Agonistes des récepteurs alpha-2 adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D058647",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.100.100.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Agonistes bêta-adrénergiques",
"alternateName": "Adrenergic beta-Agonists",
"url": "https://questionsmedicales.fr/mesh/D000318",
"about": {
"@type": "MedicalCondition",
"name": "Agonistes bêta-adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D000318",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.100.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Agonistes des récepteurs bêta-1 adrénergiques",
"alternateName": "Adrenergic beta-1 Receptor Agonists",
"url": "https://questionsmedicales.fr/mesh/D058665",
"about": {
"@type": "MedicalCondition",
"name": "Agonistes des récepteurs bêta-1 adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D058665",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.100.200.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Agonistes des récepteurs béta-2 adrénergiques",
"alternateName": "Adrenergic beta-2 Receptor Agonists",
"url": "https://questionsmedicales.fr/mesh/D058666",
"about": {
"@type": "MedicalCondition",
"name": "Agonistes des récepteurs béta-2 adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D058666",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.100.200.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Agonistes des récepteurs bêta-3 adrénergiques",
"alternateName": "Adrenergic beta-3 Receptor Agonists",
"url": "https://questionsmedicales.fr/mesh/D058667",
"about": {
"@type": "MedicalCondition",
"name": "Agonistes des récepteurs bêta-3 adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D058667",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.100.200.300"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Agonistes des récepteurs bêta-1 adrénergiques",
"alternateName": "Adrenergic beta-1 Receptor Agonists",
"url": "https://questionsmedicales.fr/mesh/D058665",
"about": {
"@type": "MedicalCondition",
"name": "Agonistes des récepteurs bêta-1 adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D058665",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.100.200.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Agonistes des récepteurs béta-2 adrénergiques",
"alternateName": "Adrenergic beta-2 Receptor Agonists",
"url": "https://questionsmedicales.fr/mesh/D058666",
"about": {
"@type": "MedicalCondition",
"name": "Agonistes des récepteurs béta-2 adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D058666",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.100.200.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Agonistes des récepteurs bêta-3 adrénergiques",
"alternateName": "Adrenergic beta-3 Receptor Agonists",
"url": "https://questionsmedicales.fr/mesh/D058667",
"about": {
"@type": "MedicalCondition",
"name": "Agonistes des récepteurs bêta-3 adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D058667",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.100.200.300"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Antagonistes adrénergiques",
"alternateName": "Adrenergic Antagonists",
"url": "https://questionsmedicales.fr/mesh/D018674",
"about": {
"@type": "MedicalCondition",
"name": "Antagonistes adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D018674",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Antagonistes alpha-adrénergiques",
"alternateName": "Adrenergic alpha-Antagonists",
"url": "https://questionsmedicales.fr/mesh/D000317",
"about": {
"@type": "MedicalCondition",
"name": "Antagonistes alpha-adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D000317",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.200.100"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Antagonistes des récepteurs alpha-1 adrénergiques",
"alternateName": "Adrenergic alpha-1 Receptor Antagonists",
"url": "https://questionsmedicales.fr/mesh/D058668",
"about": {
"@type": "MedicalCondition",
"name": "Antagonistes des récepteurs alpha-1 adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D058668",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.200.100.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antagonistes des récepteurs alpha-2 adrénergiques",
"alternateName": "Adrenergic alpha-2 Receptor Antagonists",
"url": "https://questionsmedicales.fr/mesh/D058669",
"about": {
"@type": "MedicalCondition",
"name": "Antagonistes des récepteurs alpha-2 adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D058669",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.200.100.200"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Antagonistes des récepteurs alpha-1 adrénergiques",
"alternateName": "Adrenergic alpha-1 Receptor Antagonists",
"url": "https://questionsmedicales.fr/mesh/D058668",
"about": {
"@type": "MedicalCondition",
"name": "Antagonistes des récepteurs alpha-1 adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D058668",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.200.100.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antagonistes des récepteurs alpha-2 adrénergiques",
"alternateName": "Adrenergic alpha-2 Receptor Antagonists",
"url": "https://questionsmedicales.fr/mesh/D058669",
"about": {
"@type": "MedicalCondition",
"name": "Antagonistes des récepteurs alpha-2 adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D058669",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.200.100.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antagonistes bêta-adrénergiques",
"alternateName": "Adrenergic beta-Antagonists",
"url": "https://questionsmedicales.fr/mesh/D000319",
"about": {
"@type": "MedicalCondition",
"name": "Antagonistes bêta-adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D000319",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.200.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Antagonistes des récepteurs bêta-1 adrénergiques",
"alternateName": "Adrenergic beta-1 Receptor Antagonists",
"url": "https://questionsmedicales.fr/mesh/D058671",
"about": {
"@type": "MedicalCondition",
"name": "Antagonistes des récepteurs bêta-1 adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D058671",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.200.200.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antagonistes des récepteurs bêta-2 adrénergiques",
"alternateName": "Adrenergic beta-2 Receptor Antagonists",
"url": "https://questionsmedicales.fr/mesh/D058672",
"about": {
"@type": "MedicalCondition",
"name": "Antagonistes des récepteurs bêta-2 adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D058672",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.200.200.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antagonistes des récepteurs bêta-3 adrénergiques",
"alternateName": "Adrenergic beta-3 Receptor Antagonists",
"url": "https://questionsmedicales.fr/mesh/D058673",
"about": {
"@type": "MedicalCondition",
"name": "Antagonistes des récepteurs bêta-3 adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D058673",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.200.200.300"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Antagonistes des récepteurs bêta-1 adrénergiques",
"alternateName": "Adrenergic beta-1 Receptor Antagonists",
"url": "https://questionsmedicales.fr/mesh/D058671",
"about": {
"@type": "MedicalCondition",
"name": "Antagonistes des récepteurs bêta-1 adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D058671",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.200.200.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antagonistes des récepteurs bêta-2 adrénergiques",
"alternateName": "Adrenergic beta-2 Receptor Antagonists",
"url": "https://questionsmedicales.fr/mesh/D058672",
"about": {
"@type": "MedicalCondition",
"name": "Antagonistes des récepteurs bêta-2 adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D058672",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.200.200.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Antagonistes des récepteurs bêta-3 adrénergiques",
"alternateName": "Adrenergic beta-3 Receptor Antagonists",
"url": "https://questionsmedicales.fr/mesh/D058673",
"about": {
"@type": "MedicalCondition",
"name": "Antagonistes des récepteurs bêta-3 adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D058673",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.577.050.200.200.300"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Agents adrénergiques",
"alternateName": "Adrenergic Agents",
"code": {
"@type": "MedicalCode",
"code": "D018663",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Arianne Papa",
"url": "https://questionsmedicales.fr/author/Arianne%20Papa",
"affiliation": {
"@type": "Organization",
"name": "Division of Cardiology, Department of Medicine (A.P., J.K., J.A.H., A.N.K., S.I.Z., B.-x.C., L.Y., R.L., S.L., G.L., D.R., X.L., V.T., S.O.M.), Columbia University, Vagelos College of Physicians and Surgeons, New York, NY."
}
},
{
"@type": "Person",
"name": "Jared Kushner",
"url": "https://questionsmedicales.fr/author/Jared%20Kushner",
"affiliation": {
"@type": "Organization",
"name": "Division of Cardiology, Department of Medicine (A.P., J.K., J.A.H., A.N.K., S.I.Z., B.-x.C., L.Y., R.L., S.L., G.L., D.R., X.L., V.T., S.O.M.), Columbia University, Vagelos College of Physicians and Surgeons, New York, NY."
}
},
{
"@type": "Person",
"name": "Steven O Marx",
"url": "https://questionsmedicales.fr/author/Steven%20O%20Marx",
"affiliation": {
"@type": "Organization",
"name": "Division of Cardiology, Department of Medicine (A.P., J.K., J.A.H., A.N.K., S.I.Z., B.-x.C., L.Y., R.L., S.L., G.L., D.R., X.L., V.T., S.O.M.), Columbia University, Vagelos College of Physicians and Surgeons, New York, NY."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Jessica A Hennessey",
"url": "https://questionsmedicales.fr/author/Jessica%20A%20Hennessey",
"affiliation": {
"@type": "Organization",
"name": "Division of Cardiology, Department of Medicine (A.P., J.K., J.A.H., A.N.K., S.I.Z., B.-x.C., L.Y., R.L., S.L., G.L., D.R., X.L., V.T., S.O.M.), Columbia University, Vagelos College of Physicians and Surgeons, New York, NY."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Sudoscan as substitute for quantitative sudomotor axon reflex test in composite autonomic scoring scale and its correlation with composite autonomic symptom scale 31 in type 2 diabetes.",
"datePublished": "2023-11-03",
"url": "https://questionsmedicales.fr/article/37926016",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.neucli.2023.102915"
}
},
{
"@type": "ScholarlyArticle",
"name": "Functional reserve and contractile phenotype of atrial myocardium from patients with atrial remodeling without and with atrial fibrillation.",
"datePublished": "2023-08-18",
"url": "https://questionsmedicales.fr/article/37594484",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1152/ajpheart.00355.2023"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sex differences in weight gain, blood pressure control, and responses to melanocortin-4 receptor antagonism in offspring from lean and obese parents.",
"datePublished": "2023-07-31",
"url": "https://questionsmedicales.fr/article/37519251",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1152/ajpregu.00106.2023"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of propranolol and clonidine after severe traumatic brain injury: a pilot randomized clinical trial.",
"datePublished": "2023-06-09",
"url": "https://questionsmedicales.fr/article/37296432",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13054-023-04479-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "In Cardiac Patients β-Blockers Attenuate the Decrease in Work Rate during Exercise at a Constant Submaximal Heart Rate.",
"datePublished": "2023-05-31",
"url": "https://questionsmedicales.fr/article/37257085",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1249/MSS.0000000000003230"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Actions chimiques et utilisations",
"item": "https://questionsmedicales.fr/mesh/D020164"
},
{
"@type": "ListItem",
"position": 3,
"name": "Actions pharmacologiques",
"item": "https://questionsmedicales.fr/mesh/D020228"
},
{
"@type": "ListItem",
"position": 4,
"name": "Effets physiologiques des médicaments",
"item": "https://questionsmedicales.fr/mesh/D045505"
},
{
"@type": "ListItem",
"position": 5,
"name": "Agents neuromédiateurs",
"item": "https://questionsmedicales.fr/mesh/D018377"
},
{
"@type": "ListItem",
"position": 6,
"name": "Agents adrénergiques",
"item": "https://questionsmedicales.fr/mesh/D018663"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Agents adrénergiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Agents adrénergiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-04-28",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Agents adrénergiques",
"description": "Comment diagnostiquer une surdose d'agents adrénergiques ?\nQuels tests sont utilisés pour évaluer l'effet des agents adrénergiques ?\nQuels signes cliniques indiquent une réaction aux agents adrénergiques ?\nComment évaluer l'efficacité d'un traitement adrénergique ?",
"url": "https://questionsmedicales.fr/mesh/D018663?page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Agents adrénergiques",
"description": "Quels sont les symptômes d'une réaction aux agents adrénergiques ?\nComment les agents adrénergiques affectent-ils le cœur ?\nQuels effets secondaires peuvent survenir avec ces agents ?\nLes agents adrénergiques provoquent-ils des réactions allergiques ?",
"url": "https://questionsmedicales.fr/mesh/D018663?page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Agents adrénergiques",
"description": "Comment prévenir les effets indésirables des agents adrénergiques ?\nQuelles précautions prendre avant d'utiliser des agents adrénergiques ?\nLes patients doivent-ils être informés des effets des agents adrénergiques ?\nComment éviter les interactions médicamenteuses avec ces agents ?",
"url": "https://questionsmedicales.fr/mesh/D018663?page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Agents adrénergiques",
"description": "Quels sont les principaux agents adrénergiques utilisés en médecine ?\nComment administrer l'épinéphrine en cas d'anaphylaxie ?\nQuels sont les usages cliniques des agents adrénergiques ?\nComment les agents adrénergiques sont-ils utilisés en anesthésie ?",
"url": "https://questionsmedicales.fr/mesh/D018663?page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Agents adrénergiques",
"description": "Quelles complications peuvent survenir avec les agents adrénergiques ?\nComment gérer une hypertension causée par des agents adrénergiques ?\nLes agents adrénergiques peuvent-ils provoquer des AVC ?\nQuels sont les signes d'une complication grave ?",
"url": "https://questionsmedicales.fr/mesh/D018663?page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Agents adrénergiques",
"description": "Quels facteurs augmentent le risque d'effets indésirables ?\nLes patients hypertendus sont-ils à risque avec ces agents ?\nComment le stress influence-t-il l'utilisation des agents adrénergiques ?\nLes interactions médicamenteuses augmentent-elles les risques ?",
"url": "https://questionsmedicales.fr/mesh/D018663?page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une surdose d'agents adrénergiques ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation des symptômes cliniques et des antécédents médicaux."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'effet des agents adrénergiques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de fonction cardiaque et des mesures de pression artérielle sont courants."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une réaction aux agents adrénergiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent tachycardie, hypertension et agitation psychomotrice."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un traitement adrénergique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité se mesure par l'amélioration des symptômes et des paramètres vitaux."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une réaction aux agents adrénergiques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent palpitations, anxiété, tremblements et maux de tête."
}
},
{
"@type": "Question",
"name": "Comment les agents adrénergiques affectent-ils le cœur ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils augmentent la fréquence cardiaque et la contractilité, pouvant causer des arythmies."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires peuvent survenir avec ces agents ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent hypertension, insomnie et nervosité."
}
},
{
"@type": "Question",
"name": "Les agents adrénergiques provoquent-ils des réactions allergiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réactions allergiques sont rares mais peuvent inclure éruptions cutanées et démangeaisons."
}
},
{
"@type": "Question",
"name": "Comment prévenir les effets indésirables des agents adrénergiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance étroite et un ajustement de la dose sont essentiels pour prévenir les effets indésirables."
}
},
{
"@type": "Question",
"name": "Quelles précautions prendre avant d'utiliser des agents adrénergiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évaluer les antécédents médicaux et les allergies est crucial avant l'utilisation."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils être informés des effets des agents adrénergiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informer les patients des effets secondaires potentiels est essentiel pour leur sécurité."
}
},
{
"@type": "Question",
"name": "Comment éviter les interactions médicamenteuses avec ces agents ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consulter un professionnel de santé avant de combiner des médicaments est recommandé."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux agents adrénergiques utilisés en médecine ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux incluent l'épinéphrine, la norépinéphrine et la dopamine."
}
},
{
"@type": "Question",
"name": "Comment administrer l'épinéphrine en cas d'anaphylaxie ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'épinéphrine est administrée par injection intramusculaire, généralement dans la cuisse."
}
},
{
"@type": "Question",
"name": "Quels sont les usages cliniques des agents adrénergiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont utilisés pour traiter le choc, l'asthme et les arrêts cardiaques."
}
},
{
"@type": "Question",
"name": "Comment les agents adrénergiques sont-ils utilisés en anesthésie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont utilisés pour maintenir la pression artérielle et réduire les saignements."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les agents adrénergiques ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'hypertension sévère, les arythmies et les AVC."
}
},
{
"@type": "Question",
"name": "Comment gérer une hypertension causée par des agents adrénergiques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut l'ajustement de la dose et l'utilisation d'antihypertenseurs si nécessaire."
}
},
{
"@type": "Question",
"name": "Les agents adrénergiques peuvent-ils provoquer des AVC ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une utilisation excessive peut augmenter le risque d'accidents vasculaires cérébraux."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une complication grave ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent douleur thoracique, essoufflement et perte de conscience."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'effets indésirables ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de maladies cardiaques et l'âge avancé augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les patients hypertendus sont-ils à risque avec ces agents ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients hypertendus doivent être surveillés de près lors de l'utilisation."
}
},
{
"@type": "Question",
"name": "Comment le stress influence-t-il l'utilisation des agents adrénergiques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut exacerber les effets des agents adrénergiques, augmentant les risques."
}
},
{
"@type": "Question",
"name": "Les interactions médicamenteuses augmentent-elles les risques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines interactions peuvent intensifier les effets indésirables des agents adrénergiques."
}
}
]
}
]
}
This study aims to evaluate the feasibility of substituting electrochemical skin conductance measurement using SUDOSCAN for sudomotor function testing in the Composite Autonomic Scoring Scale (CASS) a...
Fifty patients with T2DM underwent cardiovascular autonomic function testing and the SUDOSCAN test and completed the COMPASS 31 questionnaire. We developed a SUDOSCAN-based sudomotor subscore as a sub...
The total COMPASS 31 score was significantly correlated with the modified CASS score (p = 0.019 and 0.037 for the raw and weighted scores, respectively) but not with the CASS score without sudomotor a...
Atrial contractility and functional reserve in atrial remodeling (AR) without (AR/-AF) or with atrial fibrillation (AR/+AF) are not well characterized. In this study, functional measurements were perf...
We examined potential sex differences in appetite and blood pressure (BP) responses to melanocortin-4 receptor (MC4R) blockade in offspring from lean and obese parents. Offspring from normal (N) diet-...
To evaluate the safety, feasibility, and efficacy of combined adrenergic blockade with propranolol and clonidine in patients with severe traumatic brain injury (TBI)....
Administration of adrenergic blockade after severe TBI is common. To date, no prospective trial has rigorously evaluated this common therapy for benefit....
This phase II, single-center, double-blinded, pilot randomized placebo-controlled trial included patients aged 16-64 years with severe TBI (intracranial hemorrhage and Glasgow Coma Scale score ≤ 8) wi...
Dose compliance was 99%, blinding was intact, and no open-label agents were used. No treatment patient experienced dysrhythmia, myocardial infarction, or cardiac arrest. The study was stopped for futi...
Despite the safety and feasibility of adrenergic blockade with propranolol and clonidine after severe TBI, the intervention did not alter the VFD outcome. Given the widespread use of these agents in T...
Exercise prescription based on fixed heart rate (HR) values is not associated with a specific work rate (WR) during prolonged exercise. This phenomenon has never been evaluated in cardiac patients and...
Seventeen patients with coronary artery disease in stable conditions (69 ± 9 yr) were divided into two groups according to the presence (BB) or absence (no-BB) of a therapy with β-blockers, and perfor...
During INCR, HR peak was lower in BB versus no-BB ( P < 0.05), whereas no differences were observed for other variables. During HR CLAMPED , the decrease in WR needed to maintain HR constant was less ...
The decrease in WR during a 15-min exercise at a fixed HR (slightly higher than that at gas exchange threshold) was attenuated in BB, suggesting a potential role by β-adrenergic stimulation. The pheno...
It can be difficult to delineate the cause of urticarial eruptions, and in chronic cases, it can be a challenging condition to effectively treat. Several forms of urticarial eruptions are well documen...
Phospholipases A...
Prostate tissues were obtained from radical prostatectomy. Contractions were induced by electric field stimulation (EFS) and by α...
Frequency-dependent contractions of human prostate tissues induced by EFS were inhibited by 25% at 8 Hz, 38% at 16 Hz and 37% at 32 Hz by ASB14780 (1 µM), and by 32% at 16 Hz and 22% at 32 Hz by AACOC...
Our findings suggest presynaptic PLA...
Absence status epilepticus is a prolonged, generalized absence seizure that lasts more than half an hour. The mechanisms underlying the absence of status epilepticus are still not entirely understood....
Stress is thought to be an important contributing factor for eating disorders; however, neural substrates underlying the complex relationship between stress and appetite are not fully understood. Usin...
Norepinephrine (NE) is a critical neuromodulator that mediates a wide range of behavior and neurophysiology, including attention, arousal, plasticity, and memory consolidation. A major source of NE is...